Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 15, 2011
Grant Date -
Feb 10, 2011
app pub date -
Oct 18, 2010
filing date -
Sep 3, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is related to pyridine methylene azolidinone derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully